Catalyst Calendar

Thu, Sep 17, 2026

1 updates

CAPR

8:30 AM

Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress

Presentation / Abstract • Phase 3WMS late-breaking poster session Tue, Sep 29, 2026, 8:30 AM EDTcapricor.com

Mon, Aug 24, 2026

1 updates

CAPR

9:25 AM

Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA

capricor.com

Thu, Aug 13, 2026

1 updates

CAPR

4:05 PM

Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

capricor.com

Mon, Aug 10, 2026

1 updates

CAPR

8:30 AM

Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13

capricor.com

Thu, Jul 30, 2026

1 updates

CAPR

9:30 AM

Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel

capricor.com

Wed, Jul 29, 2026

1 updates

CAPR

10:05 AM

The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy

Trial Results • Phase 3Results event Wed, Jul 29, 2026, 10:05 AM EDTcapricor.com

Mon, Jul 27, 2026

1 updates

CAPR

11:00 AM

Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel

capricor.com

Fri, Jun 26, 2026

2 updates

CAPR

10:02 AM

Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

capricor.com

CAPR

9:05 AM

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

Presentation / Abstract • Phase 3Late-breaking presentation Sat, Jun 27, 2026capricor.com